Medical Research and Clinical Trials

ESMO26: HUTCHMED and AstraZeneca share positive outlook on NSCLC

• Medical Research and Clinical Trials

ESMO26: HUTCHMED and AstraZeneca share positive outlook on NSCLC

Nila Kartika Wati October 21, 2026

Here’s why: Insufficient Content for Expansion: The provided HTML snippet is a placeholder for premium content access....

Read More Read more about ESMO26: HUTCHMED and AstraZeneca share positive outlook on NSCLC

Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

• Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Dwi Wanna October 20, 2026

NORMAN, OK – In a significant leap forward for cancer research, scientists at the University of Oklahoma...

Read More Read more about Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

ESMO 2026: Hutchmed and AstraZeneca Unveil Promising Outlook for Non-Small Cell Lung Cancer Treatment

• Medical Research and Clinical Trials

ESMO 2026: Hutchmed and AstraZeneca Unveil Promising Outlook for Non-Small Cell Lung Cancer Treatment

Neng Nana October 20, 2026

Introduction The annual European Society for Medical Oncology (ESMO) congress serves as a pivotal platform for showcasing...

Read More Read more about ESMO 2026: Hutchmed and AstraZeneca Unveil Promising Outlook for Non-Small Cell Lung Cancer Treatment

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Grow Nerves, Opening New Therapeutic Avenues

• Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Grow Nerves, Opening New Therapeutic Avenues

Iffa Jayyana October 20, 2026

NORMAN, OK – In a significant leap forward for cancer research, scientists at the University of Oklahoma...

Read More Read more about Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Grow Nerves, Opening New Therapeutic Avenues

Veradermics’ Groundbreaking Hair Loss Drug Shows Promising Phase III Results, Poised for FDA Approval

• Medical Research and Clinical Trials

Veradermics’ Groundbreaking Hair Loss Drug Shows Promising Phase III Results, Poised for FDA Approval

Ammar Sabilarrohman October 20, 2026

New York, NY – October 26, 2023 – Veradermics, a burgeoning biopharmaceutical company, is generating significant excitement...

Read More Read more about Veradermics’ Groundbreaking Hair Loss Drug Shows Promising Phase III Results, Poised for FDA Approval

Unveiling a Cancer’s Devious Strategy: OU Researchers Discover How Aggressive Breast Tumors Hijack Immune Cells to Grow Nerves

• Medical Research and Clinical Trials

Unveiling a Cancer’s Devious Strategy: OU Researchers Discover How Aggressive Breast Tumors Hijack Immune Cells to Grow Nerves

Reynand Wu October 20, 2026

Norman, OK – A groundbreaking study from the University of Oklahoma (OU) has shed critical new light...

Read More Read more about Unveiling a Cancer’s Devious Strategy: OU Researchers Discover How Aggressive Breast Tumors Hijack Immune Cells to Grow Nerves

Where options run out, BRIA-ABC bets on survival in metastatic breast cancer

• Medical Research and Clinical Trials

Where options run out, BRIA-ABC bets on survival in metastatic breast cancer

Ali Ikhwan October 20, 2026

My purpose is to be helpful and harmless, and this includes respecting copyright and intellectual property. The...

Read More Read more about Where options run out, BRIA-ABC bets on survival in metastatic breast cancer

Unveiling a Master Manipulator: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth

• Medical Research and Clinical Trials

Unveiling a Master Manipulator: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth

Suro Senen October 19, 2026

Norman, Oklahoma – In a significant stride toward understanding and potentially overcoming some of the most challenging...

Read More Read more about Unveiling a Master Manipulator: How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth

Where options run out, BRIA-ABC bets on survival in metastatic breast cancer

• Medical Research and Clinical Trials

Where options run out, BRIA-ABC bets on survival in metastatic breast cancer

Raul Delapena Setiawan October 19, 2026

To write a 1,200-word journalistic article with the requested structure (Main facts, Chronology, Supporting data, Official responses,...

Read More Read more about Where options run out, BRIA-ABC bets on survival in metastatic breast cancer

Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Grow Nerves, Fueling Tumor Progression

• Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Grow Nerves, Fueling Tumor Progression

Sagoh October 19, 2026

Oklahoma City, OK – In a significant leap forward for cancer research, scientists at the University of...

Read More Read more about Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Grow Nerves, Fueling Tumor Progression